CCL11 and inflammatory bowel disease: With time, eotaxin has been recognized as a major mediator of intestinal inflammation and increased levels of eotaxin have been described in inflammatory bowel disease (IBD) including ulcerative colitis and Crohn’s disease (24, 25).